ArticleCardiovascular drugs and therapy2020

Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.

Xueling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.